fluorodeoxyglucose f18 has been researched along with Dermatofibrosarcoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Rao, Z; Wang, Y; Wu, J; Zhang, C; Zhang, S | 1 |
| Chen, H; Chen, Y; Li, M; Liu, H; Yang, X | 1 |
| Bal, C; Jain, TK; Kumar, R; Sahoo, MK; Sharma, P; Suman, S | 1 |
| Becker, JC; Hauschild, A; Hein, R; Helmbold, P; Kämpgen, E; Kellner, I; Leverkus, M; Mentzel, T; Mohr, P; Pföhler, C; Schadendorf, D; Schiller, M; Ströbel, P; Ugurel, S; Utikal, J | 1 |
| Bal, C; Jain, TK; Karunanithi, S; Kumar, R; Singh, A | 1 |
| Basu, S; Goliwale, F | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Dermatofibrosarcoma
| Article | Year |
|---|---|
18F-FDG PET/CT Prediction of an Aggressive Clinical Course for Dermatofibrosarcoma Protuberans.
Topics: Dermatofibrosarcoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2016 |
1 trial(s) available for fluorodeoxyglucose f18 and Dermatofibrosarcoma
| Article | Year |
|---|---|
Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Biomarkers; Dermatofibrosarcoma; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Imatinib Mesylate; Male; Middle Aged; Neoadjuvant Therapy; Oncogene Proteins, Fusion; Piperazines; Positron-Emission Tomography; Protein Kinase Inhibitors; Pyrimidines; Treatment Outcome | 2014 |
4 other study(ies) available for fluorodeoxyglucose f18 and Dermatofibrosarcoma
| Article | Year |
|---|---|
Comparison of 68Ga-FAPI and 18F-FDG PET/CT in Dermatofibrosarcoma Protuberans.
Topics: Dermatofibrosarcoma; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Quinolines; Skin Neoplasms | 2022 |
Increased 68 Ga-FAPI Uptake in Dermatofibrosarcoma Protuberans.
Topics: Biological Transport; Dermatofibrosarcoma; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Skin Neoplasms | 2022 |
Recurrent dermatofibrosarcoma protuberans with pulmonary metastases presenting twelve years after initial diagnosis: 18F-FDG PET/CT imaging findings.
Topics: Dermatofibrosarcoma; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Tomography, X-Ray Computed | 2014 |
18F-FDG PET/CT in a seldom case of primary duodenal dermatofibrosarcoma protuberans with lung and skeletal metastases.
Topics: Bone Neoplasms; Dermatofibrosarcoma; Duodenal Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |